Organization & Developments: Lumena

Parents

Diabetes drug development company Lumena Pharmaceuticals aims to harness a benefit that diabetics receive from gastric bypass surgery and deliver it to those patients in the form of a pill.
Focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as NASH
Most gastric bypass surgery patients are type 2 diabetics. Studies have found that in 80 percent of those patients, blood glucose levels normalized within days. It’s not a function of weight loss
Something Else Is Happening